Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4953)
All Articles published online
|
May 10, 2011 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murakami K. FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations. World J Clin Oncol 2011; 2(5): 229-236 [PMID: 21611100 DOI: 10.5306/wjco.v2.i5.229] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v2/i5/229.htm |
| Number | Citing Articles |
| 1 |
Stefanie J. Hectors, Mathilde Wagner, Cecilia Besa, Wei Huang, Bachir Taouli. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience. Contrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/5638283
|
| 2 |
F. Montravers, J.-N. Talbot. Tomographie par émission de positons en cancérologie digestive. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2012; 7(2): 1 doi: 10.1016/S1879-8527(12)55045-8
|
| 3 |
Julien Dimastromatteo, Jacob L. Houghton, Jason S. Lewis, Kimberly A. Kelly. Challenges of Pancreatic Cancer. The Cancer Journal 2015; 21(3): 188 doi: 10.1097/PPO.0000000000000109
|
| 4 |
Ryusuke Takebayashi, Kunihiko Izuishi, Yuka Yamamoto, Reiko Kameyama, Hirohito Mori, Tsutomu Masaki, Yasuyuki Suzuki. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-34
|
| 5 |
Yasemin Sanli, Baris Bakir, Serkan Kuyumcu, Zeynep Gozde Ozkan, Mine Gulluoglu, Orhan Bilge, Cuneyt Turkmen, Ayse Mudun. Hepatic Adenomatosis May Mimic Metastatic Lesions of Liver With 18F-FDG PET/CT. Clinical Nuclear Medicine 2012; 37(7): 697 doi: 10.1097/RLU.0b013e3182443ced
|
| 6 |
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. European Radiology 2018; 28(12): 5356 doi: 10.1007/s00330-018-5425-z
|
| 7 |
|
| 8 |
Jacob L. Houghton, Brian M. Zeglis, Dalya Abdel-Atti, Robert Aggeler, Ritsuko Sawada, Brian J. Agnew, Wolfgang W. Scholz, Jason S. Lewis. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proceedings of the National Academy of Sciences 2015; 112(52): 15850 doi: 10.1073/pnas.1506542112
|
| 9 |
Kyung Jin Cho, Nam Kyu Choi, Min Ho Shin, A Ri Chong. Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection. Annals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4): 194 doi: 10.14701/ahbps.2017.21.4.194
|
| 10 |
Thomas Winkens, William Rudakoff, Falk Rauchfuss, Christina Malessa, Utz Settmacher, Martin Freesmeyer. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma—Additional Benefit for Patients Considered for Liver Transplantation?. Clinical Nuclear Medicine 2021; 46(7): 532 doi: 10.1097/RLU.0000000000003576
|
| 11 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; : 891 doi: 10.1007/978-3-031-05494-5_17
|
| 12 |
Eric C. Ehman, Michael S. Torbenson, Christopher L. Hallemeier, Julie K. Heimbach, Lewis R. Roberts. Evaluation and Management of Liver Masses. 2020; : 1 doi: 10.1007/978-3-030-46699-2_1
|
| 13 |
Preethi Guniganti, Andrea S. Kierans. PET/MRI of the hepatobiliary system: Review of techniques and applications. Clinical Imaging 2021; 71: 160 doi: 10.1016/j.clinimag.2020.10.056
|
| 14 |
Annachiara Arnone, Riccardo Laudicella, Federico Caobelli, Priscilla Guglielmo, Marianna Spallino, Elisabetta Abenavoli, Anna Martini, Rossella Filice, Alessio Comis, Marco Cuzzocrea, Flavia Linguanti, Laura Evangelista, Pierpaolo Alongi. Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review. Diagnostics 2020; 10(12): 1042 doi: 10.3390/diagnostics10121042
|
| 15 |
T. Seufferlein, J.B. Bachet, E. Van Cutsem, P. Rougier. Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012; 23: vii33 doi: 10.1093/annonc/mds224
|
| 16 |
Kathryn M. Tully, Nicholas B. Sobol, Patrícia M.R. Pereira, Jason S. Lewis. Companion and Complementary Diagnostics. 2019; : 201 doi: 10.1016/B978-0-12-813539-6.00010-9
|
| 17 |
R. Ntagirabiri, S. Niyonkuru, R. Karayuba, G. Ndayisaba, G. Marerwa. Cancer du pancréas au Burundi, expérience du CHU de Kamenge. Journal Africain d'Hépato-Gastroentérologie 2012; 6(4): 312 doi: 10.1007/s12157-012-0422-3
|
| 18 |
Nerissa Therese Viola-Villegas, Samuel L. Rice, Sean Carlin, Xiaohong Wu, Michael J. Evans, Kuntal K. Sevak, Marija Drobjnak, Govind Ragupathi, Ritsuko Sawada, Wolfgang W. Scholz, Philip O. Livingston, Jason S. Lewis. Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology. Journal of Nuclear Medicine 2013; 54(11): 1876 doi: 10.2967/jnumed.113.119867
|
| 19 |
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
|
| 20 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; : 1 doi: 10.1007/978-3-319-26067-9_17-4
|
| 21 |
Shigeki Nagamachi, Ryuichi Nishii, Hideyuki Wakamatsu, Youichi Mizutani, Shogo Kiyohara, Seigo Fujita, Shigemi Futami, Tatefumi Sakae, Eiji Furukoji, Shozo Tamura, Hideo Arita, Kazuo Chijiiwa, Keiichi Kawai. The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT. Annals of Nuclear Medicine 2013; 27(6): 554 doi: 10.1007/s12149-013-0719-3
|
| 22 |
KUNIHIKO IZUISHI, YUKA YAMAMOTO, HIROHITO MORI, RIKO KAMEYAMA, SHINTARO FUJIHARA, TSUTOMU MASAKI, YASUYUKI SUZUKI. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer. Oncology Reports 2014; 31(2): 701 doi: 10.3892/or.2013.2886
|
| 23 |
Mohamad A. Eloubeidi, G. Anton Decker, Vinay Chandrasekhara, Krishnavel V. Chathadi, Dayna S. Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Kimberly Foley, Joo Ha Hwang, Terry L. Jue, Jenifer R. Lightdale, Shabana F. Pasha, John R. Saltzman, Ravi Sharaf, Amandeep K. Shergill, Brooks D. Cash, John M. DeWitt. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointestinal Endoscopy 2016; 83(1): 17 doi: 10.1016/j.gie.2015.09.009
|
| 24 |
He N Xu, Shoko Nioka, Lin Z Li. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomarker Research 2013; 1(1) doi: 10.1186/2050-7771-1-6
|
| 25 |
Matthew E. Wampole, John C. Kairys, Edith P. Mitchell, Martha L. Ankeny, Mathew L. Thakur, Eric Wickstrom, Chin-Tu Chen. Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass. PLoS ONE 2013; 8(9): e75237 doi: 10.1371/journal.pone.0075237
|